Eosinophil Count Test

Your eosinophil count tells you how many of a specific type of immune cell are circulating in your blood right now. These cells are part of your body's defense network, but unlike the white blood cells that fight everyday bacteria, eosinophils specialize in a narrower set of threats: parasitic infections, allergic reactions, and a particular flavor of inflammation driven by what immunologists call the "type 2" immune response. When eosinophils rise or fall outside their normal range, they are often the first signal that something in your immune system has shifted.

What makes this count especially useful is its specificity. A high eosinophil count does not just mean "inflammation" the way a high CRP does. It points toward a distinct set of causes, from hidden drug reactions to asthma severity to rare blood cancers. A low count, on the other hand, can flag a serious acute infection or signal that your body is under severe stress. Either way, the number carries diagnostic weight that broader immune markers cannot match.

What Eosinophils Are and Where They Come From

Eosinophils are produced in your bone marrow from stem cells, under the direction of a signaling molecule called interleukin-5 (IL-5). Once mature, they enter your bloodstream, where they make up roughly 1% to 5% of all white blood cells. From there, they migrate into tissues, especially the lining of your gut and airways, where they stand ready to respond to threats.

These cells carry granules packed with potent proteins that can kill parasites and damaged cells. But those same proteins can also injure your own tissues when eosinophils accumulate where they should not, or in numbers that overwhelm the local environment. That dual nature, protective in the right context, destructive in the wrong one, is why tracking your count matters.

Cardiovascular Risk

Eosinophils are not typically grouped with heart disease markers, but large population studies suggest they should get more attention. In a Dutch study of over 5,300 adults followed for 30 years, those with eosinophil counts at or above 275 cells per microliter had about 70% higher risk of dying from cardiovascular disease compared to those with lower counts, after adjusting for age, sex, smoking, and lung function. The association was even stronger for stroke, with roughly 2.3 times the risk of dying from cerebrovascular disease.

More recently, a study using data from over 2,100 adults in the Multi-Ethnic Study of Atherosclerosis (MESA) found that higher eosinophil counts were linked to greater buildup of plaque in the carotid arteries and more coronary artery calcium, both markers of subclinical heart disease, even after adjusting for standard cardiovascular risk factors. These findings suggest eosinophils may reflect or contribute to the kind of vascular inflammation that precedes a heart attack or stroke.

Cancer Associations

The relationship between eosinophils and cancer runs in two directions depending on the type of malignancy. For blood cancers, elevated eosinophils are a warning sign. In a Danish registry of over 356,000 people, those with severely elevated counts (at or above 1.0 x 10^9 per liter) had about 9 times the odds of being diagnosed with Hodgkin lymphoma within three years. Chronic lymphocytic leukemia and myeloproliferative neoplasms (cancers that cause the bone marrow to overproduce blood cells) also showed strong associations with elevated eosinophils.

For solid tumors, the picture reverses. An analysis of over 443,000 cancer-free adults in the UK Biobank found that higher eosinophil counts were associated with a small but consistent reduction in total cancer risk. Twelve specific cancer types, including melanoma, lung, colon, and breast cancer, showed lower incidence as eosinophil counts rose. A Mendelian randomization study, which uses genetic variants to test whether the association is likely causal, supported a protective effect of higher eosinophil counts against colorectal cancer specifically.

All-Cause Mortality

Both high and low eosinophil counts are associated with dying sooner. In the same 30-year Dutch study, elevated eosinophils predicted about 40% higher all-cause mortality after adjusting for confounders. A study of over 107,000 hemodialysis patients revealed a reverse J-shaped curve: the lowest counts carried the highest death risk, counts in the normal range had the best survival, and very high counts were again associated with increased mortality.

On the low end, a meta-analysis of 151 studies found that eosinopenia (very low eosinophil counts) during infections strongly predicted death. In COVID-19 patients, having zero eosinophils more than doubled the risk of dying. Similar patterns held for C. difficile infection, with about 2.4 times the mortality risk when eosinophils were absent. This makes eosinopenia a surprisingly useful bedside prognostic marker during acute illness.

Respiratory Disease

This is where eosinophils have their most established clinical role. In asthma, a higher blood eosinophil count identifies people with "eosinophilic asthma," a subtype that responds particularly well to inhaled corticosteroids and to newer biologic drugs that target IL-5, the molecule that drives eosinophil production. Guidelines from the Global Initiative for Asthma (GINA) use eosinophil counts to determine who should receive these targeted treatments.

In chronic obstructive pulmonary disease (COPD), eosinophil counts predict which patients benefit from adding inhaled corticosteroids to their treatment. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends checking eosinophils to guide this decision. Higher counts in younger adults without COPD have also been linked to a faster decline in lung function over time and an increased risk of developing COPD later.

Reference Ranges

Eosinophil counts are measured as part of a complete blood count (CBC) with differential. Your result will appear as an absolute count, reported in cells per microliter (cells/µL) or as x 10^3/µL. Always use the absolute count rather than the percentage, because the percentage can be misleading if your total white blood cell count is unusually high or low.

In healthy adults, median eosinophil counts are considerably lower than the upper limit of normal: about 120 cells/µL in men and 100 cells/µL in women. These typical values matter because they give you a more useful reference point than the laboratory's broad normal range. A count of 480, while technically "normal," is well above the median and worth tracking.

When Results Can Be Misleading

Eosinophil counts have a high degree of natural variability within the same person. The week-to-week coefficient of variation (a measure of how much a result bounces around on repeat testing) runs between 20% and 27%. During acute illness flares, such as a COPD exacerbation, this variability climbs to roughly 77%. That means a single reading near a clinical threshold (say, 290 cells/µL when the cutoff is 300) may not reflect your true baseline.

Time of day matters. Eosinophil counts are highest in the early morning and can drop by about 36% by noon. If you are tracking your trend over time, try to draw blood at a consistent time. Season also plays a role, with counts running roughly 20% higher in summer than winter. Corticosteroids, even inhaled or nasal formulations, can suppress your count and mask underlying eosinophilia.

Obesity and active smoking both push counts higher, which can confuse the picture if you are trying to determine whether a mild elevation reflects an allergic or inflammatory process. If your count is borderline and you are overweight or a current smoker, keep that context in mind when interpreting the result.

Tracking Your Trend

A single eosinophil count is a snapshot, and given this marker's natural variability, snapshots can mislead. The real value emerges when you track your count over time. In a study that measured eosinophils monthly for a year, people with counts consistently below 150 cells/µL stayed in that low category about 70% of the time, but those near clinical thresholds crossed back and forth frequently. Your personal trend line, not any individual number, tells the real story.

Get a baseline reading when you are feeling well, not during an acute illness, allergy flare, or while taking corticosteroids. If you are making changes, whether starting an exercise program, adjusting medications, or investigating food triggers, retest in 3 to 6 months under similar conditions (same time of day, same health status). After that, annual monitoring is reasonable for most people. If your count is near a treatment threshold or you are managing an eosinophilic condition, more frequent checks (every 3 to 4 months) give you the resolution you need to see whether your count is drifting.

When comparing results, always use the same laboratory. While inter-lab correlation is generally good (around 0.89), systematic differences between analyzers exist. Your trend is most reliable when every data point comes from the same instrument.